Catalyst Event

AbbVie Inc (ABBV) · Other

From Akros U.S. Large Cap 500 Protective Allocation Monthly Index (A500PAM)

6/2/2026, 12:00:00 AM

OtherSentiment: Positive

AbbVie announced European Commission approval for AQUIPTA® on 2026-06-02; estimated low impact as the approval was largely anticipated by the market.

Korean Translation

애브비, 2026-06-02 성인 편두통 치료제 아큅타의 유럽연합 집행위원회 판매 허가를 발표함; 시장에서 충분히 예상된 승인으로 영향은 낮을 것으로 예상됨.

Related Recent Events

View Full Timeline